Τελευταία μηνύματα

Σελίδες: 1 ... 8 9 [10]
91
https://books.google.gr/books/about/AIDS_Inc.html?id=ErIOAAAACAAJ&source=kp_cover&redir_esc=y
AIDS Inc

Virus is NOT the cause Definition of AIDS is Worthless Treatment is Poison "Anyone interested in AIDS must read this book." Laurence E. Badgley, M.D Author of Healing AIDS Naturally Investigative reporter Jon Rappoport uncovers the shocking truth about AIDS: Thousands are dying needlessly as the medical world and media pull off the biggest scandal of our time - all for the love of power and money. AIDS INC: takes you on a sizzling behind-the-scenes tour of laboratories, newsrooms and even the White House to expose the real killers behind the disease. It's the most explosive, myth-shattering book you'll read this year. Book Size: 216x140
92
Εγκλημα στο χώρο της Υγείας / Απ: 'HIV test a crime, AIDS 'cure' killed a whole generation'
« Τελευταίο μήνυμα από Rose στις 13, 2019, 21:21:24 »
https://www.amazon.co.uk/Rethinking-AIDS-Tragic-Premature-Consensus/dp/0029269059

Rethinking AIDS: The Tragic Cost of Premature Consensus Hardcover – 26 Mar 1993
by Robert Scott Root-Bernstein (Author)

When basketball hero Magic Johnson recently announced that he had tested positive for HIV, the public naturally assumed it was only a matter of time before he developed full-blown AIDS. But is the link between HIV and AIDS really established? Most physicians now believe that HIV is tantamount to a death sentence. They also believe that AIDS is a fundamentally new disease whose cause remained unknown until the discovery of HIV. That discovery was hailed as a great advance in the fight against this devastating plague, and it has been cited to justify the continuing huge expenditure of billions of dollars a year in public funds on AIDS research. But do we know that AIDS is new? Do we really know its cause? Robert Root-Bernstein, a researcher in biochemistry and autoimmune diseases, argues that AIDS is not new, and strongly criticizes the AIDS research extablishment for ignoring historical data to the contrary in their haste to declare the AIDS puzzle solved. In fact, he argues, AIDS has been around a lot longer than anyone realizes; its fundamental cause is depression of the immune system; that this can occur for many different reasons; and that the relation between HIV and AIDS may be more correlational than causal. In short, we still don't know what causes AIDS. Lifestyle theories of causation are just as plausible, given the current state of knowledge, as the HIV hypothesis. Root-Bernstein provides a thorough and authoritative, yet accessible view of the existing AIDS research, drawing on medical records to show that hundreds of cases of AIDS may have occurred in the course of the past hundred years, and presenting several plausible alternatives to the HIV hypothesis.
93
Εγκλημα στο χώρο της Υγείας / ΑΡΩΜΑ ΕΛΛΑΔΑΣ - ΚΑΡΚΙΝΟΣ
« Τελευταίο μήνυμα από Rose στις 12, 2019, 23:25:43 »
ΑΡΩΜΑ ΕΛΛΑΔΑΣ - ΚΑΡΚΙΝΟΣ
https://www.youtube.com/watch?v=QnX9Zq_cODo&t=932s
94
https://www.ncbi.nlm.nih.gov/pubmed/15630849

Format: AbstractSend to
Clin Oncol (R Coll Radiol). 2004 Dec;16( 8 ):549-60.
The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies.
Morgan G1, Ward R, Barton M.
Author information
1
Department of Radiation Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, NSW, Australia. gmorgan1@bigpond.net.au
Abstract
AIMS:
The debate on the funding and availability of cytotoxic drugs raises questions about the contribution of curative or adjuvant cytotoxic chemotherapy to survival in adult cancer patients.

MATERIALS AND METHODS:
We undertook a literature search for randomised clinical trials reporting a 5-year survival benefit attributable solely to cytotoxic chemotherapy in adult malignancies. The total number of newly diagnosed cancer patients for 22 major adult malignancies was determined from cancer registry data in Australia and from the Surveillance Epidemiology and End Results data in the USA for 1998. For each malignancy, the absolute number to benefit was the product of (a) the total number of persons with that malignancy; (b) the proportion or subgroup(s) of that malignancy showing a benefit; and (c) the percentage increase in 5-year survival due solely to cytotoxic chemotherapy. The overall contribution was the sum total of the absolute numbers showing a 5-year survival benefit expressed as a percentage of the total number for the 22 malignancies.

RESULTS:
The overall contribution of curative and adjuvant cytotoxic chemotherapy to 5-year survival in adults was estimated to be 2.3% in Australia and 2.1% in the USA.

CONCLUSION:
As the 5-year relative survival rate for cancer in Australia is now over 60%, it is clear that cytotoxic chemotherapy only makes a minor contribution to cancer survival. To justify the continued funding and availability of drugs used in cytotoxic chemotherapy, a rigorous evaluation of the cost-effectiveness and impact on quality of life is urgently required.

Comment in
The contribution of cytotoxic chemotherapy to the management of cancer. [Clin Oncol (R Coll Radiol). 2005]
PMID: 15630849 DOI: 10.1016/j.clon.2004.06.007
95
https://www.ncbi.nlm.nih.gov/pubmed/27599138

30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study.
Wallington M1, Saxon EB2, Bomb M1, Smittenaar R2, Wickenden M2, McPhail S1, Rashbass J1, Chao D3, Dewar J4, Talbot D5, Peake M6, Perren T7, Wilson C8, Dodwell D9.
Author information
1
Public Health England, London, UK.
2
Cancer Research UK, London, UK.
3
Department of Oncology, Royal Free Hospital, London, UK.
4
Department of Oncology, Ninewells Hospital & Medical School, Dundee, UK.
5
University of Oxford, Department of Oncology, Oxford, UK.
6
Public Health England, London, UK; University of Leicester, Department of Respiratory Medicine, Glenfield Hospital, Leicester, UK.
7
Leeds Institute of Cancer Research and Pathology, St James's University Hospital, Leeds, UK.
8
Oncology Centre, Addenbrooke's NHS Trust, Cambridge, UK.
9
Institute of Oncology, St James's Hospital, Leeds, UK. Electronic address: david.dodwell@nhs.net.
Erratum in
Correction to Lancet Oncol 2016; 17: 1203, 06, 08, 09, 11. [Lancet Oncol. 2016]
Abstract
BACKGROUND:
30-day mortality might be a useful indicator of avoidable harm to patients from systemic anticancer treatments, but data for this indicator are limited. The Systemic Anti-Cancer Therapy (SACT) dataset collated by Public Health England allows the assessment of factors affecting 30-day mortality in a national patient population. The aim of this first study based on the SACT dataset was to establish national 30-day mortality benchmarks for breast and lung cancer patients receiving SACT in England, and to start to identify where patient care could be improved.

METHODS:
In this population-based study, we included all women with breast cancer and all men and women with lung cancer residing in England, who were 24 years or older and who started a cycle of SACT in 2014 irrespective of the number of previous treatment cycles or programmes, and irrespective of their position within the disease trajectory. We calculated 30-day mortality after the most recent cycle of SACT for those patients. We did logistic regression analyses, adjusting for relevant factors, to examine whether patient, tumour, or treatment-related factors were associated with the risk of 30-day mortality. For each cancer type and intent, we calculated 30-day mortality rates and patient volume at the hospital trust level, and contrasted these in a funnel plot.

FINDINGS:
Between Jan 1, and Dec, 31, 2014, we included 23 228 patients with breast cancer and 9634 patients with non-small cell lung cancer (NSCLC) in our regression and trust-level analyses. 30-day mortality increased with age for both patients with breast cancer and patients with NSCLC treated with curative intent, and decreased with age for patients receiving palliative SACT (breast curative: odds ratio [OR] 1·085, 99% CI 1·040-1·132; p<0·0001; NSCLC curative: 1·045, 1·013-1·079; p=0·00033; breast palliative: 0·987, 0·977-0·996; p=0·00034; NSCLC palliative: 0·987, 0·976-0·998; p=0·0015). 30-day mortality was also significantly higher for patients receiving their first reported curative or palliative SACT versus those who received SACT previously (breast palliative: OR 2·326 99% CI 1·634-3·312; p<0·0001; NSCLC curative: 3·371, 1·554-7·316; p<0·0001; NSCLC palliative: 2·667, 2·109-3·373; p<0·0001), and for patients with worse general wellbeing (performance status 2-4) versus those who were generally well (breast curative: 6·057, 1·333-27·513; p=0·0021; breast palliative: 6·241, 4·180-9·319; p<0·0001; NSCLC palliative: 3·384, 2·276-5·032; p<0·0001). We identified trusts with mortality rates in excess of the 95% control limits; this included seven for curative breast cancer, four for palliative breast cancer, five for curative NSCLC, and seven for palliative NSCLC.

INTERPRETATION:
Our findings show that several factors affect the risk of early mortality of breast and lung cancer patients in England and that some groups are at a substantially increased risk of 30-day mortality. The identification of hospitals with significantly higher 30-day mortality rates should promote review of clinical decision making in these hospitals. Furthermore, our results highlight the importance of collecting routine data beyond clinical trials to better understand the factors placing patients at higher risk of 30-day mortality, and ultimately improve clinical decision making. Our insights into the factors affecting risk of 30-day mortality will help treating clinicians and their patients predict the balance of harms and benefits associated with SACT.

FUNDING:
Public Health England.

Copyright © 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY NC-ND license. Published by Elsevier Ltd.. All rights reserved.
96
https://naturalsociety.com/deadly-cancer-drugs-make-cancer-worse-and-kill-patients-more-quickly/

Deadly Cancer Drugs Make Cancer Worse and Kill Patients More Quickly

By Natural Society
Posted On January 19, 2012

Cancer drugs, pushed by many drug companies as the only ‘scientific’ method of combating cancer alongside chemotherapy, have been found to actually make cancer worse and kill patients more quickly. The findings come after research was conducted on the cancer drugs at the Beth Israel Deaconess Medical Center in Boston. Sold at a premium price to cancer sufferers, it turns out these drugs are not only ineffective but highly dangerous.

Something known as anti-antiogenesis is the primary function behind many such widely-used cancer drugs that were analyzed in the study. Researchers examined drugs such as imatanib (a leukemia drug that goes by the brand name Gleev.ec) and sunit.inib (a drug for gastrointestinal tumors — brand name Sutent), finding that these drugs may initially reduce tumor size but afterwards cause tumors to ‘metasize’ aggressively. This means that the tumors come back much stronger and grow much larger than their original size.

Cancer Drugs Lead to ‘Metasized’ Tumors
As a result, patients develop life-threatening tumors that oftentimes kill patients more quickly as a result of taking the drug.

When study researchers induced anti-angiogenesis in mice, there was an initial 30% decrease in the volume of the tumor over 25 days. Afterwards, however, the tumors that had metastasized to the lungs tripled. Researchers published the findings in the January 17 issue of Cancer Cell, with study authors shocked by the findings.

“Whatever manipulations we’re doing to tumors can inadvertently do something to increase the tumor numbers to become more metastatic, which is what kills patients at the end of the day,” said study author Dr. Raghu Kalluri.

“Whatever manipulations we’re doing to tumors can inadvertently do something to increase the tumor numbers to become more metastatic, which is what kills patients at the end of the day,” said study author Dr. Raghu Kalluri.

Natural Alternatives More Effective, Come Without Side Effects
It is clear that these cancer drugs are virtually ineffective at treating cancer, even killing patients who may have otherwise survived. Of course a number of natural anti-cancer substances do exist that have been found to be largely effective in reducing tumor size and most importantly combating the onset of cancer. Perhaps the most amazing anti-cancer substance for your health is high quality turmeric. Turmeric has been found to reduce tumors by an astounding 81% in recent research. And contrary to cancer drugs, turmeric does not come loaded with deadly side effects.

Quite the opposite, turmeric instead comes with beneficial properties that can prevent your risk of disease and positively affect over 560 conditions.

Vitamin D is another essential anti-cancer nutrient. Amazingly, vitamin D is much more effective than pharmaceutical drugs at fighting cancer, and is virtually a free nutrient. Instead of paying a premium price for deadly cancer drugs, your vitamin D levels can be significantly improved by soaking up some sunlight. It is important to receive a blood test to ensure you are within the optimal vitamin D level range. The correct test you should receive is 25(OH)D, also called 25-hydroxyvitamin D. The optimal range is 50-70 ng/ml, though if you are fighting cancer or heart disease it is 70-100 ng/ml.

97
https://www.naturalnews.com/055365_chemotherapy_cancer_treatment_patient_fatalities.html?fbclid=IwAR0lVN6NPZWOd4jYWMwPDKHQqxGyfZ2zHEY7V74_4eF9Qsoub5jV3LDH9s0

Shocking new study shows chemo kills half of cancer patients, not cancer itself
Tuesday, September 20, 2016 by: Amy Goodrich

(NaturalNews) A new landmark study found that up to 50 percent of people who receive chemotherapy are killed by the treatment, not cancer itself. For the first time, researchers from Public Health England and Cancer Research U.K. examined the numbers of cancer patients who died within 30 days of starting chemotherapy.

Chemotherapy is an invasive and toxic treatment to kill cancer cells. Unfortunately, chemo doesn't differentiate between a cancerous or a healthy cell. As a result, it kills all living matter on its way. Furthermore, chemo drugs are known to damage the immune system. This makes cancer patients more vulnerable to infections, which may contribute to the high mortality rates.

Chemo kills within the first 30 days
The study, which was published in The Lancet Oncology medical journal, looked at more than 23,000 women with breast cancer and nearly 10,000 men with lung cancer who underwent chemotherapy in 2014. Of those treated with chemotherapy, 1,383 died within 30 days.

As reported by the Telegraph, on average 8.4 percent of lung cancer patients and 2.4 percent of breast cancer patients died within a month. That number, however, depended hugely on the hospital.

The mortality rate at Lancashire Teaching Hospitals for those undergoing palliative chemotherapy for lung cancer, for instance, was 28 percent. But in Milton Keynes the death rate for lung cancer treatment went up to 50.9 percent.

According to Dr. Jem Rashbass, Cancer Lead for Public Health England, chemotherapy is a crucial part of cancer treatment. He, however, admitted that chemotherapy drugs are potent chemical substances with significant side effects.

He further noted that getting the balance right to aggressively treat patients can be hard. Therefore, hospitals with death rates outside the expected range have had the findings shared with them. Also, they have been asked to review their practice and data.

Doctors should be more careful about pushing toxic treatment
Furthermore, the authors of the study have advised physicians to exercise more caution in selecting which patients should receive chemotherapy. They noted that some people, such as older and more infirm patients, might be better off without it.

"I think it's important to make patients aware that there are potentially life threatening downsides to chemotherapy. And doctors should be more careful about who they treat with chemotherapy," said Professor David Dodwell, Institute of Oncology, St James Hospital, Leeds, UK.

All hospitals involved stated that since they received the notification of the high death rates, they have reviewed the information and remain certain chemotherapy was safe in all administered cases.

While chemotherapy has been used as a cancer treatment for decades, scientists are still looking for safer and more effective treatments or a possible cure. In May 2016, a study conducted at the Duke University Medical Center found that an antibody, developed from the human body's immune system, appeared to specifically target cancer cells without doing damage to healthy cells.

Effective alternative treatments do exist, but due to bad governmental policies in favor of the Big Pharma, cancer patients in most areas of the U.S. are withhold from such treatments and are forced into expensive chemotherapy treatments or face time in jail.

Remember the 17-year-old girl who was diagnosed with Hodgkin lymphoma? Last year, after seeking out alternative care, she was denied contact with her own family and placed in foster care while health authorities forced her to undergo cancer treatment against her will.
98
Παραδέχονται ότι τα φάρμακα προκαλούν ανοσολογική ανεπάρκεια, και σταματώντας τα τοξικά φάρμακα, όπως και τα ανοσοκατασταλτικά, και με σωστή διατροφή συνέρχεται ο οργανισμός.

https://el.wikipedia.org/wiki/Ανοσολογική_ανεπάρκεια

Δευτερογενής ή επίκτητη ανοσολογική ανεπάρκεια
H δευτερογενής ή επίκτητη ανοσολογική ανεπάρκεια (secondary or acquired immunodeficiency) είναι πιο συχνή από τη πρωτογενή. Παρόλο που το ανοσοκατεσταλμένο άτομο γεννήθηκε με φυσιολογικό και πλήρως λειτουργικό ανοσοποιητικό σύστημα, ένα γεγονός που συνέβη στη ζωή του οδήγησε σε προσωρινή ή μόνιμη ανεπάρκεια του ανοσοποιητικού συστήματος. Καταστάσεις που μπορούν να προκαλέσουν δευτερογενή ανοσολογική ανεπάρκεια είναι το γήρας, η εγκυμοσύνη, η μη σωστή διατροφή, ο καρκίνος, η χρήση ορισμένων φαρμάκων (π.χ. κορτικοστεροειδή, ανοσοκατασταλτικά, κ.ά.), χειρουγικές επεμβάσεις, μεταμόσχευση οργάνων καθώς και ορισμένες βακτηριακές, παρασιτικές, μυκητιασικές και ιογενείς λοιμώξεις[4][5]. Τα άτομα που πάσχουν από δευτερογενή ανοσολογική ανεπάρκεια αντιμετωπίζουν ιδιαίτερο κίνδυνο από τις λεγομένες ευκαιριακές λοιμώξεις (opportunistic infections). Η πιο γνωστή αιτία επίκτητης ανοσολογικής ανεπάρκειας είναι η ο ιός της ανθρώπινης ανοσοανεπάρκειας (Human Immunodeficiency Virus – HIV), που προκαλεί το Σύνδρομο της Επίκτητης Ανοσολογικής Ανεπάρκειας, πιο γνωστό ως AIDS (Acquired Immunodeficiency Syndrome). Η αντιμετώπιση της δευτερογενούς ανοσολογικής ανεπάρκειας εξαρτάται από το αίτιο που την προκάλεσε. Συνήθως η άρση της αιτίας θα επαναφέρει τη φυσιολογική λειτουργία του ανοσοποιητικού συστήματος (π.χ. διακοπή λήψης κορτικοστεροειδών ή ανοσοκατασταλτικών φαρμάκων, σωστή και πλήρης διατροφή).

99
https://www.rodokipos.com/news/megali-i-niki-kai-gia-ton-rodokipo-kai-gia-tin-fysiki-iatriki-sti-chora-mas/

https://www.facebook.com/marina.tonti/posts/1253756331463862

Marina Tonti 11/10/2019

Είπα να σας το κρατήσω για έκπληξη, όταν καθαρογραφεί η Απόφαση... Αλλά θυμάστε που με είχαν κάνει μήνυση για Ψευδείς Ειδήσεις, και για Απάτη, η Παρέα από τα Χοαξάκια, που με ταλαιπωρούν εδώ και 3 χρόνια?

Ηθελαν τα καημένα να με κλείσουν 10 χρόνια φυλακή, αλλά δεν τα κατάφεραν, και στεναχωριέμαι πάρα πολύ για αυτούς, δεν ξέρω πως να τους παρηγορήσω... Προσπάθησαν τόσο πολύ τα καημένα, και δεν κατάφεραν να μου κάνουν ζημιά, εμένα την κακιά που αναστατώνω τον κόσμο κατά των χημικών φαρμάκων και βοηθάμε με φυσικές αγωγές, απολύτως ακίνδυνες και εγγυημένες...

Ευχαριστώ πάρα πολύ όλους τους Φίλους και τις Φίλες, που συμπαραστάθηκαν σε αυτόν τον Ιερό Αγώνα, όλα τα Αδέλφια που με βοήθησαν καταθέτοντας τις περιπτώσεις τους που θεραπεύτηκαν, καθώς και βελτιώθηκε σημαντικά η Υγεία τους, από τις Αγωγές του Ροδόκηπου, και ναι πραγματικά, οι επιστημονικές μας θέσεις και οι αποδείξεις ήταν τόσο ισχυρές, και αληθινότατες, που ΚΕΡΔΙΣΑΜΕ...

Επίσης ειλικρινά, για πρώτη φορά, είδα Αληθινή Δικαιοσύνη στην χώρα... Πραγματικά δεν περίμενα, τέτοια στήριξη από τον Εισαγγελέα και τον Δικαστή, αλλά ειλικρινά, τους αφοπλίσαμε τελείως, δεν υπήρχε καμία δικαιολογία να μην με Αθωώσουν...

Φυσικά ένιωσα συγκλονισμένη, όπως κάθε Διαφωτιστής, και Κοινωνικός Επαναστάτης στο Παρελθόν, πέρασα την ίδια Μύηση και Εμπειρία, και πραγματικά είχα προπληρώσει με πολλές θυσίες, ψυχική ταλαιπωρία, δοκιμασίες, αλλά και οδύνη, αυτή τη Νίκη.

"Αν θέλετε καταδικάστε με, αλλά εγώ δεν πρόκειται να σιωπήσω, να μην λέω την Αλήθεια, πως το Μεγαλύτερο Εγκλημα της εποχής μας, είναι οι παρενέργειες των χημικών φαρμάκων, προκαλείται στην κυριολεξία ΓΕΝΟΚΤΟΝΙΑ, και στην χώρα μας, αλλά και Παγκόσμια και έχουμε χρέος να το σταματήσουμε."

Και μετά δεν άντεξα, έκλαψα με λυγμούς, είχα δύο μέρες να κοιμηθώ, μαζεύοντας όλες τις έρευνες, καλύπτοντας κάθε πιθανότητα... Ο Δικηγόρος, φύλακας Αγγελος μου, καταπληκτικός Ιδεολόγος τα είπε τέλεια, ο Ορφέας πάντα ο Στρατηγός, και φυσικά οι μάρτυρες, είναι αληθινοί Ηρωες, που τόλμησαν να σταθούν δίπλα μου, σε μία τόσο δύσκολη Αποστολή, καθώς διαλύαμε και γκρεμίζαμε, το σάπιο Σύστημα, έτσι ώστε να ελευθερωθούν όλοι οι Ασθενείς από την χρόνια εκμετάλλευση, καταστροφή της Υγείας τους, και της Ζωής τους, από τις παρενέργειες των χημικών φαρμάκων.

Δεν θα ξεχάσω καθόλου όλη την στήριξη του Εισαγγελέα, και του Δικαστή, και ειδικά όταν είπε το κορυφαίο...

"Μπορεί η συμβατική ιατρική να μην θεραπεύει, αλλά η Φυσική Ιατρική του Ροδόκηπου να θεραπεύει."

Ατύχησαν οι Φίλοι μας, δεν κατάφεραν να με καταδικάσουν...
Οι Φυσικές θεραπείες στην Ελλάδα μας, μόλις Ελευθερώθηκαν.... ολωσδιόλου... και ήρθε ο Καιρός να εισχωρήσουν Αληθινοί Επιστήμονες στο χώρο της Υγείας που νοιάζονται ειλικρινά να θεραπεύουν...

Μετά από αυτό τον ξευτελισμό που έχει υποστεί το Σύστημα, δεν πρόκειται να ξαναενοχλήσουν ποτέ ξανά, κανέναν φυσικό θεραπευτή...

Τέλος καλό, όλα καλά, τώρα προχωράμε παρακάτω...

Εχουμε ένα Δημόσιο Σύστημα Υγείας, να αλλάξουμε, και έναν Ελληνικό Λαό να Ελευθέρωσουμε ΟΛΟΙ ΜΑΖΙ...

Ο Αγώνας Συνεχίζεται μέχρι Τελικής Νίκης!!!

Εσεται Ημαρ!!!!
100
[ΔΙΑΛΟΓΙΣΜΟΣ] ΚΑΙ ΠΩΣ ΘΑ ΑΛΛΑΞΕΙ TΗ ΖΩΗ ΣΟΥ!
https://www.youtube.com/watch?v=4EgxvQw6iYU
Σελίδες: 1 ... 8 9 [10]